Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
Semaglutide behaves as a glucagon-like-peptide-1 receptor agonist that judiciously links to as well as ignites the glucagon-like-peptide-1 receptor, which is the supreme target for native glucagon-like-peptide-1
To help address these needs, companies are developing different mechanisms of action for obesity treatments to meet future demand
Clinical trials demonstrate that GLP-1 medications produce weight reductions of 15 to 22 percent of body weight, substantially outperforming topiramate and other older weight loss agents
US$ 24.93
US$ 27.89
US$ 21.45
US$ 22.29
:max_bytes(150000):strip_icc()/GettyImages-1314279091-24245c02206549599efbddf5e60fbe7a.jpg)
US$ 22.20
US$ 26.58
US$ 22.12
US$ 20.48
US$ 20.56
